Inflawell® improves neutrophil-to-lymphocyte ratio and shortens hospitalization in patients with moderate COVID-19, in a randomized double-blind placebo-controlled clinical trial.
Barzin Tond S, Balenci L, Khajavirad N, Salehi M, Tafakhori A, Shahmohammadi MR, Ghiasvand F, Jafari S, Abolghasemi S, Mokhtari F, Mahmoodi Baram S, Zarei T, Kazemi D, Mohammadnejad E, Shah-Hosseini A, Haghbin Toutounchi A, Fallah S, Riazi A, Karima S.
Barzin Tond S, et al. Among authors: riazi a.
Inflammopharmacology. 2022 Apr;30(2):465-475. doi: 10.1007/s10787-022-00928-w. Epub 2022 Feb 24.
Inflammopharmacology. 2022.
PMID: 35201518
Free PMC article.
Clinical Trial.